James Investment Research Inc Argenx Se Transaction History

James Investment Research Inc

  • $853 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 26, 2021
SELL
$257.11 - $319.92 $10,798 - $13,436
-42 Closed
0 $0
Q1 2021

Apr 22, 2021
BUY
$268.3 - $380.31 $8,049 - $11,409
30 Added 250.0%
42 $11,000
Q4 2020

Jan 27, 2021
SELL
$248.13 - $308.36 $8,932 - $11,100
-36 Reduced 75.0%
12 $4,000
Q3 2020

Oct 23, 2020
BUY
$215.51 - $272.51 $10,344 - $13,080
48 New
48 $13,000

Others Institutions Holding ARGX

# of Institutions
400
Shares Held
30.9M
Call Options Held
376K
Put Options Held
489K
View Full List

About ARGENX SE

ARGX Quotes by TradingView
  • Ticker ARGX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 55,323,800
  • Market Cap $34.8B
  • Description
  • argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for the treatment of patients with myasthenia gravis, immune thrombocytopenia, pemphigus vulgaris, ...
More about ARGX
Track This Portfolio

Track James Investment Research Inc Portfolio

Follow James Investment Research Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of James Investment Research Inc, based on Form 13F filings with the SEC.

News

Stay updated on James Investment Research Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email